Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Journal of Neuroscience Methods|June 28, 2016
Micro-computed tomography in murine models of cerebral cavernous malformations as a paradigm for brain diseaseRomuald Girard, Hussein A Zeineddine, Courtney Orsbon, et al.
Translational Stroke Research|July 9, 2024
Except for Robust Outliers, Rapamycin Increases Lesion Burden in a Murine Model of Cerebral Cavernous MalformationsRoberto J Alcazar-Felix, Robert Shenkar, Christian R Benavides, et al.
The Journal of Clinical Investigation|May 27, 2021
Astrocytes propel neurovascular dysfunction during cerebral cavernous malformation lesion formationMiguel Alejandro Lopez-Ramirez, Catherine Chinhchu Lai, Shady Ibrahim Soliman, et al.
Cell Communication and Signaling : CCS|January 9, 2024
Transcriptomic signatures of individual cell types in cerebral cavernous malformationYing Li, Romuald Girard, Abhinav Srinath, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|January 20, 2025
Circulating molecules reflect imaging biomarkers of hemorrhage in cerebral cavernous malformationsStephanie F Hage, Dehua E Bi, Serena Kinkade, et al.
Neurobiology of Disease|December 11, 2024
Common lipidomic signatures across distinct acute brain injuries in patient outcome predictionSanttu Hellström, Antti Sajanti, Abhinav Srinath, et al.
Journal of Magnetic Resonance Imaging : JMRI|September 14, 2019
Phantom validation of quantitative susceptibility and dynamic contrast-enhanced permeability MR sequences across instruments and sitesNicholas Hobson, Sean P Polster, Ying Cao, et al.
Brain & Spine|December 9, 2025
Shared metabolomic signatures for prognostic precision across brain injuriesSanttu Hellström, Antti Sajanti, Aditya Jhaveri, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 28, 2018
Phenotypic characterization of murine models of cerebral cavernous malformationsHussein A Zeineddine, Romuald Girard, Laleh Saadat, et al.
The Lancet. Neurology|March 22, 2025
Safety and efficacy of atorvastatin for rebleeding in cerebral cavernous malformations (AT CASH EPOC): a phase 1/2a, randomised placebo-controlled trialIssam A Awad, Roberto J Alcazar-Felix, Agnieszka Stadnik, et al.
Pageof 8